Date :
Place : United States of America, Boston
Website :https://ckd3-summit.com/
Contact Person:Erin Thomas
Description:
Advancing More Personalized Therapies for Rare and Common Kidney Diseases. Prices: USD 2699.00 - USD 5896.00. Time: 08:00 to 18:00.Deadline for abstracts/proposals : 17th March 2025
Organized By :
Keynote Speakers :
Conference Highlights :Home - 7th CKD3 Summit
Welcome to the 7th Chronic Kidney Disease Drug Development Summit 2025 - the definitive industry forum for CKD Drug Development!
March 17-19 2025Boston, MA
Register Before Friday, 17 January &Save Up to $850
AdvancingMore Personalized Therapies for Rare & Common Kidney Diseases
March 17-19,2025| Boston, MA
The transformative era of kidney drug development is here, with 2024 bringing landmark advancements, includingNovartis’ Borealis Biosciencesandapprovals inIgAN, TravereTherapeutics, and industry-defining acquisitions byBiogenandVertex. Breakthrough therapies like SGLT2 inhibitors, GLP-1s, and MRAs continue to reshape the CKD treatment paradigm, while the FDA’s accelerated pathways fuel unprecedented innovation. We arewitnessinga renaissance in chronic kidney disease research and development and treatment.
Check the event website for more details.